Approval · Notice of Compliance 13122 · 2012
ALDARA: Notice of Compliance 13122
Issued March 16, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13122
- Date
- March 16, 2012
- Company
- Medicis Pharmaceutical CorpScottsdale, Arizona, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Immune Response Modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALDARA | 02239505 | Marketed |
Medicinal ingredients
- IMIQUIMOD 50 MG per G